File No. 333-269630 (the “Registration Statement”)
Ladies and Gentlemen:
Black Bird Biotech, Inc. (the “Company”) hereby withdraws its request for acceleration with respect to the Registration Statement submitted to the Securities and Exchange Commission on February 15, 2023.
Please call Eric Newlan at (940) 367-6154, should there be any questions with respect to this letter.
Respectfully submitted,
/s/ Fabian G. Deneault
Fabian G. Deneault
President
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.